Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 251

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study

Open access
McArthur, G.A., Maio, M., Arance, A., Nathan, P., Blank, C., Avril, M.-F., Garbe, C., Hauschild, A., Schadendorf, D., Hamid, O., Fluck, M., Thebeau, M., Schachter, J., Kefford, R., Chamberlain, M., Makrutzki, M., Robson, S., Gonzalez, R., Margolin, K. · 2017 · Annals of Oncology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/annonc/mdw641

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 13

  1. Davies, 2011, Prognostic factors for survival in melanoma patients with brain metastases, Cancer, 117, 1687, 10.1002/cncr.25634 · DOI · Paper page
  2. Fife, 2004, Determinants of outcome in melanoma patients with cerebral metastases, J Clin Oncol, 22, 1293, 10.1200/JCO.2004.08.140 · DOI · Paper page
  3. Eigentler, 2011, Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma, Cancer, 117, 1697, 10.1002/cncr.25631 · doi:10.1002/cncr.25631
  4. Goyal, 2015, Clinical management of multiple melanoma brain metastases: a systematic review, JAMA Oncol, 1, 668, 10.1001/jamaoncol.2015.1206 · DOI
  5. Douglas, 2002, The treatment of brain metastases from malignant melanoma, Semin Oncol, 29, 518, 10.1053/sonc.2002.35247 · doi:10.1053/sonc.2002.35247
  6. Agarwala, 2004, Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study, J Clin Oncol, 22, 2101, 10.1200/JCO.2004.11.044 · DOI · Paper page
  7. Avril, 2004, Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study, J Clin Oncol, 22, 1118, 10.1200/JCO.2004.04.165 · DOI · Paper page
  8. Long, 2015, Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial, Lancet, 386, 444, 10.1016/S0140-6736(15)60898-4 · DOI · Paper page
  9. Ascierto, 2016, Progression-free survival landmark analysis: a critical endpoint in melanoma clinical trials, Lancet Oncol, pii, S1470
  10. Long, 2012, Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial, Lancet Oncol, 13, 1087, 10.1016/S1470-2045(12)70431-X · DOI · Paper page
  11. Dummer, 2014, Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study, Eur J Cancer, 50, 611, 10.1016/j.ejca.2013.11.002 · DOI · Paper page
  12. Larkin, 2014, Combined vemurafenib and cobimetinib in BRAF-mutated melanoma, N Engl J Med, 371, 1867, 10.1056/NEJMoa1408868 · DOI · Paper page
  13. Chen, 2014, Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target, Clin Can Res, 20, 5537, 10.1158/1078-0432.CCR-13-3003 · DOI · Paper page

Cited by

See all 251

Metadata

Authors
McArthur, G. A., Maio, M., Arance, A., Nathan, P., Blank, C., Avril, M.-F., Garbe, C., Hauschild, A., Schadendorf, D., Hamid, O., Fluck, M., Thebeau, M., Schachter, J., Kefford, R., Chamberlain, M., Makrutzki, M., Robson, S., Gonzalez, R., & Margolin, K.
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2017-03
Volume
28
Issue
3
Pages
634-641
ISSN
0923-7534 (ISSN-L)
OpenAlex
W2562656839
Cited by
251
References
3
FWCI
13.09
Type
journal article
Language
en
Open access
bronze
Licence
Funders
F. Hoffmann-La Roche Ltd

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study. https://app.cochat.ai/papers/10.1093/annonc/mdw641
The paper
McArthur, G. A., Maio, M., Arance, A., Nathan, P., Blank, C., Avril, M.-F., Garbe, C., Hauschild, A., Schadendorf, D., Hamid, O., Fluck, M., Thebeau, M., Schachter, J., Kefford, R., Chamberlain, M., Makrutzki, M., Robson, S., Gonzalez, R., & Margolin, K. (2017). Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study. Annals of Oncology. https://doi.org/10.1093/annonc/mdw641

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.